Does taking naltrexone after Sublocade (buprenorphine) eliminate it from the system for good?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Naltrexone After Sublocade: Effects on Buprenorphine Elimination

No, taking naltrexone after Sublocade (buprenorphine) will not eliminate it from the system for good, but it will block its effects while potentially precipitating withdrawal symptoms. 1

Pharmacological Interactions Between Naltrexone and Sublocade

  • Naltrexone is a competitive opioid receptor antagonist that blocks the effects of opioids, including buprenorphine (Sublocade) 1
  • Sublocade (extended-release buprenorphine) has a prolonged presence in the body, with detectable levels for months after administration 2
  • Taking naltrexone while Sublocade is still in your system doesn't eliminate the buprenorphine molecules, but rather competes with them at opioid receptor sites 1

Potential Consequences of Taking Naltrexone After Sublocade

  • Precipitated withdrawal: Naltrexone can displace buprenorphine from opioid receptors, potentially causing acute withdrawal symptoms 2
  • Blocking effects: Naltrexone will block the therapeutic effects of buprenorphine while both medications are present in the system 1
  • Duration of antagonist effects: Naltrexone's effects persist for 2-3 days after discontinuation due to its active metabolite (6-β-naltrexol) 1
  • Extended-release naltrexone formulations have even longer durations of action (24-30 days) 2

Clinical Considerations

  • Patients transitioning between these medications require careful management to avoid severe withdrawal 3, 4
  • The Society for Perioperative Assessment and Quality Improvement recommends:
    • Oral naltrexone should be held 2-3 days before procedures requiring opioids 2
    • Extended-release naltrexone should be held 24-30 days before procedures requiring opioids 2
  • Some clinical protocols use very low dose naltrexone with tapering buprenorphine doses to manage transitions, but this requires medical supervision 3, 4

Important Cautions

  • Self-administering naltrexone while on Sublocade can lead to severe withdrawal symptoms 2, 1
  • Medical supervision is essential when transitioning between these medications 5, 3, 4
  • Patients may require higher doses of opioid analgesics if they need pain management while transitioning due to receptor upregulation 1
  • Any transition between these medications should be managed by healthcare providers experienced in addiction medicine 6, 7

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.